通过骨质结晶抑制和骨质促进促进,用于协同治疗骨质疏松症的阿伦德罗酸的多聚胺驱动结晶
Xingsen Yang1, Yu Fan1, Junhao Liang1,2,3
1Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai 201804, P. R. China.
ACS nano
|August 5, 2024
概括
研究人员开发了一种新的无载体纳米粒子,将阿伦德罗纳酸和抗硬质素剂结合起来,用于治疗骨质疏松症. 这种双作用纳米组件同时抑制骨的再吸收,并促进骨的形成,以提高治疗效果.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 目前使用双酸盐 (抗吸收剂) 或抗硬质素剂 (骨质生成剂) 的骨质疏松症治疗方法存在局限性.
- 由于对骨重塑过程的间接干预,个别疗法的有效性不令人满意.
- 使用双药纳米组件的协同方法是必要的,但仍然难以捉摸.
研究的目的:
- 为增强骨质疏松症治疗创造一种无载体双药纳米组件.
- 将抗吸收性阿伦德罗酸盐 (ALN) 和抗克莱洛斯多聚胺 (Apt) 结合成一个单一的纳米粒子.
- 为了研究这种新型纳米组件的协同抗骨质疏松疗效.
主要方法:
- 开发了一种核酸驱动的结晶方法来合成ALN-Apt纳米组件.
- 利用DNA和ALN的骨结合特性,在断性骨中有针对性的积累.
- 利用骨的酸性微环境来触发持续的药物释放.
主要成果:
- 纳米组件有效地保护了聚酸免受降解,并降低了阿伦德罗纳酸细胞毒性.
- 实现了针对性地将两种药物释放到取消性骨,并持续释放这两种药物.
- 观察到ALN同时抑制骨质细胞活性,并通过Apt促进骨质生成.
结论:
- 这项研究开创了由核酸驱动的双酸盐结晶成双药纳米组件的先驱.
- 开发的纳米组件通过同时直接干预,证明了增强的抗骨质疏松疗效.
- 这项工作为DNA-无机纳米复合材料在治疗病理疾病方面建立了可通用的策略.
相关概念视频
01:21Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
01:31Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K